A carregar...
Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment
In head and neck cancer management, there is a need for tailored approaches to optimally implement clinical outcomes. Based on the assumption that efficacy and long-term toxicity are not satisfactory for standard concurrent platinum-based chemoradiotherapy, several trials have been designed to test...
Na minha lista:
| Publicado no: | J Pers Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8151395/ https://ncbi.nlm.nih.gov/pubmed/34068797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11050393 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|